New drug combo tested for Tough-to-Treat head and neck cancers
Disease control
Ongoing
This study is testing a new drug, FID-007, given alongside an existing cancer drug called cetuximab. It aims to see if this combination can help control advanced head and neck cancer that has come back or spread after prior treatment. Researchers will compare two different dosing…
Phase: PHASE2 • Sponsor: Fulgent Pharma LLC. • Aim: Disease control
Last updated Mar 23, 2026 15:14 UTC